Demethylzeylasteral
如果您对该产品感兴趣的话,可以
产品名称:
Demethylzeylasteral
产品型号:
GOY-Y2097
产品展商:
谷研
产品文档:
无相关文档
发布时间:2023-04-26
简单介绍
DemethylzeylasteralDMSO: 250 mg/mL (520.19 mM)
Demethylzeylasteral
的详细介绍
性能参数
|
产品名称
|
Demethylzeylasteral
|
规格
|
10mM*1mL in DMSO 1mg 5mg 10mg 20mg
|
货号
|
GOY-Y2097
|
含量
|
>98.00%
|
CAS
|
107316-88-1
|
别名
|
N/A
|
|
|
化学名
|
N/A
|
分子式
|
C29H36O6
|
分子量
|
分子 480.59
|
溶解度
|
DMSO: 250 mg/mL (520.19 mM)
|
储存条件
|
Store at -20°C
|
General tips
|
|
用途
|
仅供科研
|
价格
|
电询
|
|
详细内容
|
Demethylzeylasteral is a triterpene compound isolated from Tripterygium wilfordii Hook F, with anti-inflammatory, immunosuppressive and anti-tumor activities[1][2][3][4][5]. Demethylzeylasteral can significantly alleviates atherosclerosis (AS)[5]. Demethylzeylasteral inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways[2].
[1]. Zhang K, et al. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis. Cell Death Dis. 2018 Oct 10;9(10):1035. [2]. Li L, et al. Demethylzeylasteral (T-96) inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways. Naunyn Schmiedebergs Arch Pharmacol. 2019 May;392(5):593-603. [3]. Wang Q, et al. Demethylzeylasteral ameliorates inflammation in a rat model of unilateral ureteral obstruction through inhibiting activation of the NF?κB pathway. Mol Med Rep. 2017 Jul;16(1):373-379. [4]. Zhao Y, et al. Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells. Cell Death Dis. 2017 Oct 26;8(10):e3133. [5]. Experimental study of the anti-atherosclerotic effect of demethylzeylasteral. Exp Ther Med. 2017 Jun;13(6):2787-2792.
|
公司正在销售的产品:
溴氯甲烷 99.5% 1,3,5-**基吡唑 97%
3-溴-1-丙醇 97% 香兰素胺盐酸盐 99%
3-溴苯甲醛 97% 辣椒素 97%
2-二乙氨基氯乙烷盐酸盐 99% 辣椒素 分析标准品,>98%
2-氯吡啶 99% 砷 99.995% metals basis
2-氯异氰酸乙酯 97% 三氧化二砷 AR(剧毒品)
|
SRS11-921mg 5mg 10mg 25mg>98.00%Cas No. 1467047-25-1C22H28N2O2
SR 168321mg 5mg 10mg 25mg>98.00%Cas No. 2088135-12-8C17H12ClN3O4
SPK-60110mg 50mg 100mg 200mg>98.00%Cas No. 1096687-52-3C11H15KOS2
SPI 11225mg 50mg 100mg 250mg>98.00%Cas No. 1051387-90-6C22H17FN4O5S
Stearamide100mg 250mg 500mg 1g>98.00%Cas No. 124-26-5C18H37NO
Talarozole R enantiomer5mg 10mg 25mg 50mg>98.00%Cas No. 870093-23-5C21H23N5S
Tadalafil10mM (in 1mL DMSO) 50mg 100mg 500mg>98.00%Cas No. 171596-29-5C22H19N3O4
|